AUTONOMIX MEDICAL INC. - COMMON STOCK

Autonomix Secures Principal Investigators and Completes Clinical Training for First Human Study

22 Feb 2024 07:00:00 By Nasdaq GlobeNewswire

Autonomix Begins Human POC Clinical Trial Targeting Multi-Billion-Dollar Pancreatic Cancer Market

16 Feb 2024 07:00:00 By Nasdaq GlobeNewswire

Autonomix Medical, Inc. Reports Third Quarter FY2024 Financial Results and Reiterates Upcoming Key Milestones

14 Feb 2024 07:05:00 By Nasdaq GlobeNewswire

Autonomix Medical, Inc. Receives Ethics Committee Authorization for Proof-of-Concept Human Clinical Study Evaluating Proprietary Ablation Technology for Treatment of Pancreatic Cancer Pain

06 Feb 2024 07:50:00 By Nasdaq GlobeNewswire

Autonomix Medical, Inc. (NASDAQ: AMIX) to Present at the Virtual Investor New to the Street Event

01 Feb 2024 07:35:00 By Nasdaq GlobeNewswire

Autonomix Medical, Inc. to Ring the Nasdaq Stock Market Closing Bell on Thursday, February 1, 2024

31 Jan 2024 07:45:00 By Nasdaq GlobeNewswire

Autonomix Medical, Inc. Completes $8,000,000 Transaction for Exclusive Worldwide Rights to Technology for Cardiology Field Use – Over 100 patents in portfolio

30 Jan 2024 11:00:00 By Nasdaq GlobeNewswire

Autonomix Medical, Inc. Completes Transaction for Exclusive Worldwide Rights to Technology for Cardiology Field Use

30 Jan 2024 08:05:00 By Nasdaq GlobeNewswire

Autonomix Medical, Inc. (NASDAQ: AMIX) Commences Trading on NASDAQ

29 Jan 2024 07:05:00 By Nasdaq GlobeNewswire